Republicans object to proposed generic label rule in US
This article was originally published in SRA
Executive Summary
A group of US Republicans have expressed what they called "grave concerns" in a letter to Food and Drug Administration Commissioner Dr Margaret Hamburg about her agency's proposal issued this past November to permit generic drug makers to independently update their US product labeling with newly-acquired safety information before regulators review those changes1-3.